Log In
BCIQ
Print this Print this
 

GC1102

  Manage Alerts
Collapse Summary General Information
Company Green Cross Corp.
DescriptionRecombinant human mAb against hepatitis B virus (HBV)
Molecular Target Hepatitis B surface antigen (HBsAg)
Mechanism of ActionBinds hepatitis B surface antigen (HBsAg); Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis B virus (HBV)
Indication DetailsPrevent hepatitis B infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today